The analysis of AURKA expression, in correlation with the patient survival in the ICGC‐LIRI‐JP cohort (HCV+ HCC samples, n = 112), revealed that patients with higher AURKA expression had shorter OS [HR = 1.95 (1.39–2.75), p = 0.002] (Table 3).75 Here, AURKA is linked to hepatocellular carcinoma.